ROSEN, A LEADING AND RANKED FIRM, Encourages Akebia Therapeutics, Inc. Investors with Losses Over $1...

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Akebia Therapeutics, Inc. (NASDAQ: AKBA) between June 28, 2018

Related Keywords

China ,Chinese ,Phillip Kim ,Akebia Therapeutics Inc ,Chinese Company ,Securities Class Action Services ,Rosen Law Firm ,Nasdaq ,Encourages Akebia Therapeutics ,Glosses Over ,Akebia Therapeutics ,Class Period ,Law Firm ,Class Action Services ,